For: | Gupta K, Perchik JD, Fang AM, Porter KK, Rais-Bahrami S. Augmenting prostate magnetic resonance imaging reporting to incorporate diagnostic recommendations based upon clinical risk calculators. World J Radiol 2022; 14(8): 249-255 [PMID: 36160831 DOI: 10.4329/wjr.v14.i8.249] |
---|---|
URL: | https://www.wjgnet.com/1949-8470/full/v14/i8/249.htm |
Number | Citing Articles |
1 |
Anthony Bruccoliere, Vivie Tran, Naseem Helo, Abdul Awal, Stephanie Stroever, Werner T. W. de Riese. Novel clinical risk calculator for improving cancer predictability of mpMRI fusion biopsy in prostates. International Urology and Nephrology 2024; 56(9): 2851 doi: 10.1007/s11255-024-04037-1
|
2 |
Yi Cen, Shourui Feng, Yuyu Xu, Churuo Zhang, Xiangjin Lin, Xuan Ye, Zeyu Zha, Haiyan Wang, Guangbin Zhu, Gurudeeban Selvaraj. miR-455-3p has superior diagnostic potential to PSA in peripheral blood for prostate cancer. PLOS ONE 2025; 20(2): e0317385 doi: 10.1371/journal.pone.0317385
|